ClinicalTrials.govpublic full text
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
effects of immunotherapy, metastatic/recurrent cervical cancer, cervical adenocarcinoma, cervical adenosquamous cell carcinoma, cervical squamous cell carcinoma, cervical small cell carcinoma
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 121351 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.